Primary prophylaxis with pegylated G-CSF is associated with improved treatment completion and progression-free survival in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study

Key Points

• This research examines the effects of pegylated G-CSF on treatment completion and survival rates in cervical cancer patients receiving chemoradiotherapy.
• Retrospective cohort analysis
• Comparison of treatment outcomes between patients receiving pegylated G-CSF and those who did not
• Assessment of neutropenia rates and treatment adherence
• Reduced severe neutropenia observed in patients receiving pegylated G-CSF
• Increased adherence to planned chemoradiotherapy protocol
• Longer progression-free survival noted in the treated group